How many institutions held STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share in Q1 2022?

111 institutional investors reported STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share for Q1 2022. Use the holders table for investor-level position and value details.

SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO)

Q: What does CUSIP 869367102 represent in this 13F holders report?

CUSIP 869367102 is the security identifier for STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 869367102

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 16,611,035
Total 13F shares: 41,606,389
Share change: +277,716
Total reported value: $341,990,813
Price per share: $8.22
Number of holders: 111
Value change: -$38,514,469
Number of buys: 59
Number of sells: 58

Quarterly Holders Quick Answers

What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 869367102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	22%	3,700,043	$55,057,000	—	31 Dec 2021	13F
FRANKLIN RESOURCES INC	13F	Company	20%	3,267,947	$48,627,000	—	31 Dec 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	16%	2,708,975	$40,310,000	—	31 Dec 2021	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	15%	2,437,795	$36,274,000	—	31 Dec 2021	13F
First Light Asset Management, LLC	13F	Company	14%	2,246,588	$33,429,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	13%	2,117,807	$31,513,000	—	31 Dec 2021	13F
BAILLIE GIFFORD & CO	13F	Company	11%	1,855,250	$27,606,000	—	31 Dec 2021	13F
SV Health Investors, LLC	13F	Company	11%	1,824,542	$27,149,000	—	31 Dec 2021	13F
FRAZIER MANAGEMENT LLC	13F	Company	11%	1,776,479	$26,434,000	—	31 Dec 2021	13F
Samsara BioCapital, LLC	13F	Company	10%	1,675,579	$24,933,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	9.6%	1,590,837	$23,672,000	—	31 Dec 2021	13F
Holocene Advisors, LP	13F	Company	9.5%	1,583,579	$23,564,000	—	31 Dec 2021	13F
LOOMIS SAYLES & CO L P	13F	Company	6.7%	1,115,835	$16,604,000	—	31 Dec 2021	13F
BVF INC/IL	13F	Company	5.6%	925,148	$13,766,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	4.5%	743,679	$11,065,000	—	31 Dec 2021	13F
FMR LLC	13F	Company	4.4%	737,300	$10,971,000	—	31 Dec 2021	13F
Opaleye Management Inc.	13F	Company	4.1%	680,000	$10,118,000	—	31 Dec 2021	13F
CITADEL ADVISORS LLC	13F	Company	3.6%	596,770	$8,880,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	3.3%	545,224	$8,112,000	—	31 Dec 2021	13F
Lombard Odier Asset Management (Switzerland) SA	13F	Company	3.2%	528,442	$7,863,000	—	31 Dec 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.2%	362,553	$5,395,000	—	31 Dec 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.2%	360,765	$5,369,000	—	31 Dec 2021	13F
BARCLAYS PLC	13F	Company	2.1%	354,387	$5,273,000	—	31 Dec 2021	13F
Tekla Capital Management LLC	13F	Company	2%	327,850	$4,878,000	—	31 Dec 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	1.7%	281,702	$4,192,000	—	31 Dec 2021	13F
Pentwater Capital Management LP	13F	Company	1.4%	230,000	$3,422,000	—	31 Dec 2021	13F
NOMURA HOLDINGS INC	13F	Company	1.3%	221,434	$3,302,000	—	31 Dec 2021	13F
Parkman Healthcare Partners LLC	13F	Company	1.3%	221,219	$3,292,000	—	31 Dec 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.3%	220,045	$3,279,000	—	31 Dec 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.3%	215,566	$3,208,000	—	31 Dec 2021	13F
Verition Fund Management LLC	13F	Company	1.1%	184,765	$2,749,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	1.1%	182,200	$2,711,000	—	31 Dec 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1%	173,957	$2,588,000	—	31 Dec 2021	13F
Invesco Ltd.	13F	Company	1%	166,222	$2,474,000	—	31 Dec 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.96%	160,000	$2,381,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.9%	149,615	$2,226,000	—	31 Dec 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.88%	145,635	$2,167,000	—	31 Dec 2021	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.88%	145,351	$2,163,000	—	31 Dec 2021	13F
Neuberger Berman Group LLC	13F	Company	0.88%	146,745	$2,142,000	—	31 Dec 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.87%	143,718	$2,137,000	—	31 Dec 2021	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.84%	139,331	$2,073,000	—	31 Dec 2021	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.77%	127,925	$1,904,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.7%	116,430	$1,733,000	—	31 Dec 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.68%	113,083	$1,683,000	—	31 Dec 2021	13F
Endurant Capital Management LP	13F	Company	0.67%	111,803	$1,664,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.66%	109,549	$1,631,000	—	31 Dec 2021	13F
Hudson Bay Capital Management LP	13F	Company	0.61%	101,500	$1,510,000	—	31 Dec 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.57%	94,300	$1,403,000	—	31 Dec 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.49%	81,129	$1,207,000	—	31 Dec 2021	13F
Walleye Capital LLC	13F	Company	0.45%	75,412	$1,122,000	—	31 Dec 2021	13F

Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q1 2022

As of 31 Mar 2022, SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,606,389 shares. The largest 10 holders included FRANKLIN RESOURCES INC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, STATE STREET CORP, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, Holocene Advisors, LP, and Frazier Life Sciences Management, L.P.. This page lists 111 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

114

Q1 2022 holders

111

Holder diff

-3

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.